In this issue:
Patient-led sensorguided pump therapy
Masked nocturnal hypertension: diabetes risk marker
HbA1c and microvascular complications
DURABLE trial: 24-week results
Premixed combinations of biphasic insulin aspart
Type 1 diabetes in 0−14 year olds
Please login below to download this issue (PDF)